Jim Cramer’s Charitable Trust, the portfolio managed by the CNBC Investing Club host, increased its stake in Constellation Brands on Thursday, citing a broad market move into oversold territory as a signal to deploy cash. The trust purchased 60 shares of the alcoholic beverage maker at a price of roughly $140 per share, bringing its total holding to 550 shares. This move elevates the stock’s weight within the portfolio to 2%, up from 1.8%.
Cramer noted that his trading discipline dictates investing when market indicators suggest excessive selling. The S&P Oscillator officially entered oversold territory following Wednesday’s session, dropping to -5.68%. Despite this new purchase, the trust retains a cash position slightly above 15%. The decision to buy Constellation Brands follows an initial position opened last Monday, part of a broader strategy to diversify the portfolio away from companies heavily tied to the artificial intelligence data center buildout.
The renewed interest in Constellation Brands is driven by a resurgence in its beer division. Data from NielsenIQ indicates that the company’s beer sales shifted from a decline in September to growth in October. The most recent figures, covering the four weeks ending November 7, show sales remained positive, increasing by 1.5%. Cramer believes this trend could help the company reach the upper end of its full-year earnings forecast. Additionally, the stock trades at less than 12 times earnings, offers a dividend yield of approximately 3%, and generates sufficient cash flow to support share repurchases. He also suggested the company could benefit from potential easing of immigration policies if the current administration wins the mid-term elections.
In separate news, Advanced Micro Devices (AMD) shares declined by about 6% on Thursday after the investment firm Hunterbrook disclosed a short position. Hunterbrook alleged that AMD faces similar risks regarding AI sales in China as Nvidia. However, Cramer cautioned against overreacting to the report, noting that Hunterbrook’s own records do not independently establish a violation of export laws. The trust is currently awaiting AMD’s response to the allegations before making any further trades in that sector.
Leave a Reply